|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REGULATES MYOGENESIS AND MUSCLE REGENERATION
BY ACTIVATING p38 MAPK
1 Department of Medicine, Baylor College of Medicine, Houston, Texas, United States
* To whom correspondence should be addressed. E-mail: yiping{at}bcm.tmc.edu.
Although p38 MAPK activation is essential for myogenesis, the upstream signaling mechanism that activates p38 during myogenesis remains undefined. We recently reported that p38 activation, myogenesis, and regeneration in cardiotoxin-injured soleus muscle is impaired in TNF-
receptor double knockout (p55-/-p75-/-) mice. To fully evaluate the role of TNF-
in myogenic activation of p38, we tried to determine if p38 activation in differentiating myoblasts requires autocrine TNF-
, and whether forced activation of p38 rescues impaired myogenesis and regeneration in p55-/-p75-/- soleus. We observed an increase of TNF-
release from C2C12 or mouse primary myoblasts placed in low serum differentiation medium. A TNF-
-neutralizing antibody added to differentiation medium blocked p38 activation, and suppressed differentiation markers MEF-2C, myogenin, p21 and myosin heavy chain in C2C12 myoblasts. Conversely, recombinant TNF-
added to differentiation medium stimulated myogenesis at 0.05 ng/ml while inhibited it at 0.5 and 5 ng/ml. In addition, differentiation medium-induced p38 activation and myogenesis were compromised in primary myoblasts prepared from p55-/-p75-/- mice. Increased TNF-
release was also seen in cardiotoxin-injured soleus over the course of regenetation. Forced activation of p38 via the constitutive activator of p38, MKK6bE, rescued impaired myogenesis and regeneration in cardiotoxin-injured p55-/-p75-/- soleus. These results indicate that TNF-
regulates myogenesis and muscle regeneration as a key activator of p38.
This article has been cited by other articles:
![]() |
J. Alter, D. Rozentzweig, and E. Bengal Inhibition of Myoblast Differentiation by Tumor Necrosis Factor {alpha} Is Mediated by c-Jun N-terminal Kinase 1 and Leukemia Inhibitory Factor J. Biol. Chem., August 22, 2008; 283(34): 23224 - 23234. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Kang, G.-U. Bae, M.-J. Yi, Y.-J. Yang, J.-E. Oh, G. Takaesu, Y. T. Zhou, B. C. Low, and R. S. Krauss A Cdo-Bnip-2-Cdc42 signaling pathway regulates p38{alpha}/{beta} MAPK activity and myogenic differentiation J. Cell Biol., August 11, 2008; 182(3): 497 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bakkar, J. Wang, K. J. Ladner, H. Wang, J. M. Dahlman, M. Carathers, S. Acharyya, M. A. Rudnicki, A. D. Hollenbach, and D. C. Guttridge IKK/NF-{kappa}B regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis J. Cell Biol., February 25, 2008; 180(4): 787 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D Sin and W D. Reid Is inflammation good, bad or irrelevant for skeletal muscles in COPD? Thorax, February 1, 2008; 63(2): 95 - 96. [Full Text] [PDF] |
||||
![]() |
I. Plaisance, C. Morandi, C. Murigande, and M. Brink TNF-{alpha} increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E241 - E250. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. J. Langen and A. M. W. J. Schols Inflammation: friend or foe of muscle remodelling in COPD? Eur. Respir. J., October 1, 2007; 30(4): 605 - 607. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |